Early Alert: Convenience Kits Issue from Medline
Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.
The latest headlines across every section, pulled from official and open-access sources.
Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.
V. Leung et al.
G. Faolotto et al.
More than 4,000 Brigham and Women’s Hospital nurses and 450 home health workers launched Massachusetts’ largest-ever healthcare strike this week over stalled contract talks on wages and benefits. The strike quickly prompted Governor Maura Healey to step in and convene both sides at the State House, but it remains unclear whether a deal is near. The post MGB Nurses, Home Health Staff Launch Strike Over Wages, Benefits appeared first on MedCity News .
GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both “next generation” drugs involved flunk clinical trials.
In the Original Investigation titled “Early Neurodevelopmental Outcomes in Children With Congenital Heart Disease,” published June 1, 2026, there was an error in the Article Information section. The Funding/Support section should have read: “This project was supported by the Cardiac Neurodevelopmental Outcome Collaborative (CNOC), the Pediatric Cardiac Critical Care Consortium (PC4), and the Children’s Heart Foundation through their support for integrated registry initiatives as a part of Cardiac Networks United.” This article has been corrected.
In the Original Investigation titled “Life-Sustaining Treatment Decisions and Parent Caregiving Experiences for Children With Medical Complexity,” published June 11, 2026, there were errors in Table 3. For the subtheme titled, “Emotional-rational entanglement,” the second quote should have been attributed to a “39-year-old father of 7-year-old child with Goldenhar syndrome,” and the third quote should have been attributed to a “37-year-old mother of 4-year-old twins born prematurely.” In the abbreviations footnote, CMC should have been spelled out as “children with medical complexity.” This…
Substance Use and Addiction
This cross-sectional study examines US state-level variation in days at home among older dually eligible Medicare beneficiaries with Alzheimer disease and related dementias (ADRD).
This cross-sectional study investigates trends in Escherichia coli and Klebsiella pneumoniae antimicrobial resistance in urinary samples from 6 African countries, 2010 to 2022.
This cohort study examines the association of P2Y purinergic receptor 12 (P2Y12) inhibitor antiplatelet use with stroke severity and in-hospital outcomes among patients with spontaneous intracerebral hemorrhage who used the antiplatelet therapy 7 days before hospitalization.
This cross-sectional study uses urine drug testing specimens to examine spatiotemporal trends in xylazine detection and relative concentration among samples positive for fentanyl from 2023 to 2025.
This diagnostic study investigates the ability of a previously trained artificial intelligence (AI) system to interpret blind sweep ultrasonography scans for gestational age estimation to generalize to new clinical environments.
This cohort study examines the association of the sustained availability of a dedicated high school health course with the prevalence of student-reported past 30-day substance use.
This cohort study compares sex-related differences in long-term all-cause and cause-specific mortality between male and female patients with cirrhosis.
The Life Sciences Sector Plan sets out a vision and an action plan to drive growth, innovation, and better health outcomes.
Progress report on delivering the Life Sciences Sector Plan.
Life Sciences sector attracts over £3 billion in new public-private investment in 12 months, reflecting international confidence in UK science and innovation.
FDA approval of Vera Therapeutics’ Trutakna makes it first in a new class of medicines designed to block two targets to treat immunoglobulin A nephropathy, an autoimmune disease that can progress to end-stage renal failure. Competition looms from Vertex Pharmaceuticals, on track to receive a November regulatory decision for a drug designed to block the same two proteins. The post Vera Therapeutics’ First-in-Class Kidney Disease Drug Lands Speedy FDA Approval appeared first on MedCity News .
Pearl’s $110 million raise includes a $50 million equity investment led by Andreessen Horowitz with participation from Viking Global Investors, AlleyCorp and Ulysses Capital, as well as a $60 million debt facility led by Trinity Capital. The post Pearl Health Lands $110M to Support Value-Based Care for Medicare Patients appeared first on MedCity News .
Many startups and established companies focused on drug testing on human data in preclinical studies have been boosted by FDA’s move away from reliance on animal testing towards organoid, organ-on-a-chip, and other in silico technologies. A Connecticut startup believes whole-organ testing should be an essential part of this mix. The post Organ-on-a-chip, Organoids, but Drug Testing on Whole Organs? This Startup is Betting On It appeared first on MedCity News .
Exploring the effect of 6 weeks of sleep restriction (SR) of 1.5 hours per night on energy balance and body weight regulation.
For high-risk patients with primary mitral valve regurgitation (MR), the novel Neonova transcatheter edge-to-edge repair (TEER) system was safe and effective, with a high rate of event-free survival and sustained clinical and echocardiographic improvements through two years, according to a prospective study published June 29 in JACC: Asia.
FDA’s final rule, Revising the National Drug Code Format and Drug Label Barcode Requirements, adopts a uniform, 12-digit format for the national drug code (NDC).